JT-003

· Jeil Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JT-003, covering 2022-03-25 to 2022-03-25. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Efficacy and Safety of JT-003 add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin [Phase 3]

See pricing